Nurse Practitioner · Moore, OK
NPI
1548841430
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3917 Carmona Lakes Dr
Moore, OK, 73160
Phone (405) 306-7073
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
409 services
Medicare patients, 2024
144
Average age 69
Drug cost, 2024
$3.6M
981 prescriptions
Company payments, 2025
$1,014
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie T Chan was code 99214 (office e&m - established), 303 times for 131 patients. In total Julie T Chan billed 409 services in 5 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 303 | 131 | $51.85 | $16K |
| 99215 Office E&M - Established | Office | 73 | 32 | $86.08 | $6,284 |
| 38222 Other Organ Systems | Office | 28 | 23 | $45.39 | $1,271 |
By year: 2022 $32K for 554 services; 2023 $22K for 400 services; 2024 $23K for 409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie T Chan prescribed most often to Medicare patients was Acyclovir, with 135 prescriptions and refills. In total Julie T Chan wrote 981 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 135 | 210 | 33 | $1,286 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 59 | 74 | 13 | $255 |
| Sprycel Dasatinib | 56 | 56 | Under 11 | $626K |
| Gabapentin Generic | 42 | 60 | 11 | $247 |
| Jakafi Ruxolitinib Phosphate | 36 | 36 | Under 11 | $607K |
| Allopurinol Generic | 34 | 49 | 11 | $238 |
| Hydroxyurea Generic | 33 | 37 | Under 11 | $434 |
| Venclexta Venetoclax | 32 | 32 | Under 11 | $267K |
| Fluconazole Generic | 30 | 38 | 12 | $1,747 |
| Zarxio Filgrastim-Sndz | 30 | 30 | 12 | $133K |
| Levofloxacin Generic | 28 | 32 | 12 | $370 |
| Procrit Epoetin Alfa | 27 | 27 | Under 11 | $150K |
| Imbruvica Ibrutinib | 24 | 24 | Under 11 | $486K |
| Valacyclovir Valacyclovir Hcl | 24 | 26 | Under 11 | $1,117 |
| Calquence Acalabrutinib Maleate | 18 | 18 | Under 11 | $261K |
Brand drugs: 340 claims; generic drugs: 641 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie T Chan $1,014 ($1,014 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $171.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $171 |
| Abbvie Inc. ABBV | 8 | $146 |
| Daiichi Sankyo Inc. 4568.T | 5 | $116 |
| Legend Biotech USA Inc. LEGN | 5 | $91.62 |
| Lilly USA, LLC LLY | 1 | $81.74 |
| Syndax Pharmaceuticals, Inc. SNDX | 3 | $52.96 |
| Genentech USA, Inc. ROG.SW | 2 | $42.85 |
| Kyowa Kirin, Inc. 4151.T | 2 | $41.28 |
| Celgene Corporation BMY | 2 | $37.67 |
| Bard Peripheral Vascular, Inc. BDX | 2 | $37.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.